narciclasine has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badhe, BA; Bhat, BV; Dhas, BB; Kingsley, MK; Parija, SC | 1 |
| Jia, L; Li, Y; Qi, P; Tang, R; Zheng, J | 1 |
2 other study(ies) available for narciclasine and Blood Poisoning
| Article | Year |
|---|---|
Narciclasine improves outcome in sepsis among neonatal rats via inhibition of calprotectin and alleviating inflammatory responses.
Topics: Acute Lung Injury; Amaryllidaceae Alkaloids; Anemia; Animals; Animals, Newborn; Bacterial Load; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte L1 Antigen Complex; Liver; Phenanthridines; Phosphorylation; Rats; S100 Proteins; Sepsis; Signal Transduction; Survival Analysis; Toll-Like Receptor 4; Transcription Factor RelA; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Narciclasine attenuates sepsis-induced myocardial injury by modulating autophagy.
Topics: Adenine; Amaryllidaceae Alkaloids; Animals; Autophagy; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phenanthridines; Sepsis; Up-Regulation | 2021 |